Catalyst Pharmaceutical
CPRX
CPRX
140 hedge funds and large institutions have $299M invested in Catalyst Pharmaceutical in 2020 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 40 increasing their positions, 47 reducing their positions, and 15 closing their positions.
Holders
140
Holders Change
+9
Holders Change %
+6.87%
% of All Funds
2.88%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
24
Increased
40
Reduced
47
Closed
15
Calls
$1.01M
Puts
$134K
Net Calls
+$876K
Net Calls Change
+$296K
Top Buyers
| 1 |
NM
1
Newtyn Management
New York
|
$4.62M |
| 2 |
2
Man Group
London,
United Kingdom
|
$4.85M |
| 3 |
AC
3
Armistice Capital
New York
|
$28.6M |
| 4 |
SFM
4
Sphera Funds Management
Tel Aviv,
Israel
|
$3.38M |
| 5 |
RA
5
Royce & Associates
New York
|
$6.05M |
Top Sellers
| 1 |
MP
1
Mangrove Partners
Greenwich,
Connecticut
|
$14.5M |
| 2 |
2
BlackRock
New York
|
$35.3M |
| 3 |
3
Marshall Wace
London,
United Kingdom
|
$1.52M |
| 4 |
4
State Street
Boston,
Massachusetts
|
$30.8M |
| 5 |
5
Citadel Advisors
Miami,
Florida
|
$0 |
